학술논문

A Case of TAVR Complicated by Severe Functional Mitral Regurgitation.
Document Type
Report
Author
Lepage-Mireault G; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.; Martucci G; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.; Piazza N; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.; Overtchouk P; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.; Buithieu J; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.; Mousavi N; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada.; De Varennes B; Division of Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada.; Lachapelle K; Division of Cardiac Surgery, McGill University Health Centre, Montreal, Quebec, Canada.; Spaziano M; Division of Cardiology, McGill University Health Centre, Montreal, Quebec, Canada. Electronic address: marco.spaziano@mcgill.ca.
Source
Publisher: Elsevier Country of Publication: England NLM ID: 8510280 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1916-7075 (Electronic) Linking ISSN: 0828282X NLM ISO Abbreviation: Can J Cardiol Subsets: MEDLINE
Subject
Language
English
Abstract
Mitral regurgitation (MR) is a known complication of transcatheter aortic valve replacement (TAVR). We report a case of a 90-year-old man with severe symptomatic aortic stenosis who underwent elective TAVR. The procedure was complicated by severe functional MR from left ventricular stunning and dilatation caused by hypotension throughout the procedure. An Impella CP (Abiomed, Inc, Danvers, MA) was inserted to unload the left ventricle and decrease its size with subsequent improvement in MR severity, which was sustained after Impella CP removal. In conclusion, we present the first case of successful management of post-TAVR severe functional MR with an Impella CP.
(Copyright © 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)